Citations

Clear

3942 citation(s) found for "To, Van".

Key Insights From the International ICU Diary Conference 2025
Nydahl, Peter, Ewens, Bev, Debue, Anne‐Sophie , Fiorilla, Xavier, Gabriel, Kristin, Galazzi, Alessandro , Gallie, Louise , Groth, Nikolas, Hickey, Carly, Hudson, Mark, Lynch, Fiona , Maxwell, Nicola G , Mol, Margo van, Rose, Louise, Tantam, Kate , Karnatovskaia, Lioudmila V. , Jones, Christina, Nydahl, Peter , van Mol, Margo , Tantam, Kate , Nydahl, Peter , Ewens, Beverley , Debue, Anne-Sophie , Galazzi, Alessandro , Renner, Caroline I. E. , Rose, Louise , Jones, Christina

Mayo Clinic

Nursing in Critical Care | March 31, 2026 | Volume: 31 | Issue: 3 | Pages: No page available

10.1111/nicc.70430 | PMID 41913061 Get It

ABSTRACT We report on the 2025 International ICU Diary Conference that provided a comprehensive update on current knowledge, innovations and global practices related to ICU diaries. Held in a 6‐week online format, the event featured 23 speakers and was attended by mean 69.7 (SD 20.5) participants per session. Topics included development of ICU diaries, use in special settings, digital diaries, survivors' and families' experiences, Post‐Intensive‐Care Syndrome and follow‐up and implementation projects. Highlights were innovative solutions for digital diaries and the report of persons with lived and living experiences with diaries, changing the focus on humanising critical care. Relevance for Practice ICU diaries support patient‐ and family‐centred care and should be implemented more widely across healthcare systems. Their successful adoption requires contextual adaptation and policy support, with future development likely to be shaped by the increasing use of digital ICU diaries.
Whole Metagenomic Profiling Identifies a Gut Microbial Signature for Chronic Pancreatitis via Machine Learning
Bartelli, Thais F., Sahin, Ismet, Hoffman, Kristi L. , Petrosino, Joseph, Zhao, Jing, Wood, Amy, Ayvaz, Tulin, Surathu, Anil , Cagigas, M. Navarro , Barcenas, Erick Carrasco, Mata, Tomera, Nguyen, Vincent Kim, Zulbaran-Rojas, Alejandro, White, James R., Ajami, Nadim, Yadav, Dhiraj, Conwell, Darwin L., Serrano, Jose, Pandol, Stephen J., Fogel, EL, Eden, Stephen K Van Den, Vege, S. S., Topazian, Mark D., Park, Walter G., Hart, Phil A., Forsmark, Chris, Bellin, Melena D., Maitra, Anirban, Kim, Michael, Buren, George Van , Fisher, William E., McAllister, Florencia , Behalf, on, Park, Walter G. , Bartelli, Thais Fernanda , Baydogan, Seyda , Petrosino, Joseph F. , Blackburn, Kyle Warren , Zulbaran‐Rojas, Alejandro , Li, Li , Faraoni, Erika Yanil , White, James R., Ajami, Nadim J. , Yadav, Dhiraj, Conwell, Darwin L. , Serrano, José , Pandol, Stephen J , Vege, Santhi Swaroop , Topazian, Mark , Forsmark, Chris E. , Bellin, Melena D. , Maitra, Anirban , Bhutani, Manoop S.

Mayo Clinic

Pancreas | March 30, 2026 | Volume: 55 | Issue: 5 | Pages: e458-e468

10.1097/mpa.0000000000002618 | PMID 41910593 Get It

Background: Pancreatitis significantly alters the microbial composition of the oral and intestinal compartments, causing dysbiosis that may contribute to disease mechanisms and potentially serve as a basis for diagnosis or treatment. Objective: To determine whether the oral or gut microbial signature can classify chronic pancreatitis (CP). Methods: Stool samples (n=707) were collected from participants in the Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED). Samples were distributed among 200 healthy (HC), 310 CP, 49 acute pancreatitis (AP), and 148 recurrent acute pancreatitis (RAP). In addition, saliva samples were collected for a subset of participants (n=156). Whole genome sequencing was performed to assess microbiome composition. Machine learning algorithms were utilized to identify a signature with microbial features predictive of CP. Results: Gut alpha diversity was significantly decreased in AP, RAP, and CP compared with HC, with CP exhibiting the lowest diversity. In contrast, oral microbial diversity showed no significant variation across groups. Beta diversity analysis revealed distinct gut microbiome compositions between HC and pancreatitis subtypes, with CP showing the most pronounced differences. Random forest models using gut microbial species demonstrated robust predictive performance for CP using a minimum of 10 species (Area under the curve—AUC: 0.834; accuracy: 0.774). Despite similarities in gut microbiome composition across pancreatitis subtypes, a unique gut microbial signature for CP was identified highlighting the microbiome’s potential in CP diagnosis. Conclusion: Our study reveals a gut microbial signature predictive of CP using machine learning models in a large US multi-institutional cohort.
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced RET Fusion–Positive Non–Small Cell Lung Cancer
Besse, Benjamin, Subbiah, Vivek, Curigliano, G., Bowles, Daniel W. , Doebele, Robert C. , Mansfield, Aaron S. , Baik, Christina S. , Lopes, Gilberto , Paz-Ares, Luis , Taylor, Matthew H. , Tan, Daniel S.W., Alonso, G. , Gadgeel, Shirish M., Kalemkerian, Gregory P. , Ou, S.-H.I., Wekken, Anthonie J. van der , Becerra, Carlos R., Evangelist, Makenzi Colleen, Griesinger, Frank, Lou, Yanyan , Mazières, Julien, Melear, Jason M., Narang, Mohit , Saxena, Ashish, Thomas, Michael, Thomassen, Amber , Lee, Dae Ho, Kim, Dong-Wan, Gainor, Justin F., Subbiah, Vivek , Besse, Benjamin , Besse, Benjamin , Subbiah, Vivek , Curigliano, Giuseppe , Tan, Daniel S W , Gadgeel, Shirish , Ou, Sai-Hong I , van der Wekken, Anthonie J , Liu, Stephen V , Lou, Yanyan , Mazières, Julien , Melear, Jason M , Narang, Mohit , Thomas, Michael , Lee, Dae Ho , Kim, Dong-Wan , Gainor, Justin F , Mansfield, Aaron S , Bowles, Daniel W , Curigliano, Giuseppe , Paz‐Ares, Luis , Gadgeel, Shirish M. , Griesinger, Frank , Liu, Stephen V. , Saxena, Ashish , Thomas, Michael , Wang, Sophia Y. , Kim, Dong‐Wan , Gainor, Justin F. , Taylor, Matthew H.

Mayo Clinic

Journal of Clinical Oncology | March 26, 2026 | Volume: 44 | Issue: 13 | Pages: 1190-1197

10.1200/jco-25-01489 | PMID 41886723 Get It

RET fusions appear in 1%-2% of non–small cell lung cancers (NSCLCs). The results from the ARROW study (ClinicalTrials.gov identifier: NCT03037385 ) supported US Food and Drug Administration approval of pralsetinib, an oral selective RET inhibitor, for metastatic RET -altered NSCLC and RET fusion–positive thyroid cancers. ARROW was a phase I/II open-label study of pralsetinib 400 mg once daily in RET fusion–positive NSCLCs. Coprimary end points were overall response rate (ORR) and safety. Key secondary end points included duration of response, progression-free survival, and overall survival (OS). At data lock (May 20, 2024), 281 patients initiated pralsetinib (median treatment duration, 15.0 months). ORR (measurable disease patients; n = 259) was 78% (95% CI, 69 to 86) for treatment-naïve patients and 63% (95% CI, 54 to 71) for prior platinum-based chemotherapy patients. Median OS was 44.3 months (95% CI, 30.9 to 53.1), 50.1 months (95% CI, 28.3 to not reached) in treatment-naïve patients, and 39.7 months (95% CI, 27.8 to 53.2) in prior platinum patients. Common grade ≥3 treatment-related adverse events were anemia (21%), hypertension (15%), and decreased neutrophils (13%). Three treatment-related deaths occurred (pneumonia, n = 2; interstitial lung disease and rhabdomyolysis, n = 1 each). Safety was consistent with previous ARROW reports; no hypersensitivity was reported in patients receiving prior immunotherapies. Pralsetinib produced robust, durable responses with manageable safety in treatment-naïve and previously treated patients with RET fusion–positive NSCLCs, confirming previous findings with longer follow-up.
Artificial intelligence‐based statistical modeling delineates architectural distortion in focal cortical dysplasia
Cannon, Andrew , Tian, Roland, Ebner, Blake , Burkett, Brian J. , Gompel, Jamie Van, Hartley, Christopher P., Moreira, Roger K. , Raghunathan, Aditya, Gompel, Jamie J. Van , Burkett, Brian , Van Gompel, Jamie J , Wong-Kisiel, Lily C. , Watson, Robert E., Wong‐Kisiel, Lily C. , Hartley, Christopher P.

Mayo Clinic

Brain Pathology | March 26, 2026 | Volume: 36 | Issue: 5 | Pages: No page available

10.1111/bpa.70096 | PMID 42767799 Get It

Abstract In epilepsy patients lacking magnetic resonance imaging‐visible lesions such as focal cortical dysplasia (FCD), surgical resections target regions with abnormal electroencephalographic (EEG) activity. However, histopathological identification of subtle cortical architectural abnormalities in these specimens remains challenging. We investigated whether artificial intelligence (AI)‐based morphometric and spatial analysis of NeuN‐stained cortical sections could detect neuronal architectural disorganization in epilepsy resections, including regions without definitive histologic dysplasia. Whole slide images were generated from 83 FCD regions and 19 neurologically normal autopsy controls. Regions of interest were annotated in QuPath as FCD, FCD‐adjacent, FCD‐distant, apparently normal (abnormal EEG without histologic dysplasia), and true normal (autopsy controls). NeuN‐positive neurons were detected using QuPath (90% sensitivity, 12% false positive rate). Spatial and morphometric features—including neuronal clustering, distribution inhomogeneity, and nuclear morphology—were extracted and used to train a multinomial, Least Absolute Shrinkage and Selection Operator‐regularized regression classifier. The classifier achieved 70.6% accuracy in subregion classification and 88.2% accuracy in overall specimen diagnosis. Notably, regions with abnormal EEG but lacking histologic dysplasia exhibited quantifiable architectural disorganization similar to those seen in areas adjacent to FCD and distinct from control tissue. AI‐driven analysis of neuronal morphology and spatial distribution reveals subtle cortical disorganization in epilepsy resections, including in histologically ambiguous regions. Further investigation is warranted to determine if this methodology can enhance the diagnostic yield of neuropathological evaluation and support more precise surgical targeting in epilepsy.
Mechanical dyssynchrony and septal–lateral perfusion heterogeneity predict adverse left ventricular remodelling beyond ECG-defined LBBB
Brandão, Simone Cristina Soares, Joseph, Lee , Brown, Jenifer M. , Lopez, Diana, Lemley, M A R K, Ramirez, Giselle, Kavanagh, P A U L, Kriekinge, Serge D. Van , Builoff, Valerie , Divakaran, Sanjay, Weber, Brittany, Hainer, Jon, Carre, Sylvain , Blankstein, Ron, Dorbala, Sharmila, Le, Viet T, Mason, Steve, Chareonthaitawee, Panithaya, Wopperer, Samuel, Rosamond, Thomas, Berman, D., Dey, Damini, Carli, Marcelo F Di, Slomka, Piotr J, Huck, Daniel M, Soares Brandão, Simone Cristina , Kavanagh, Paul , Divakaran, Sanjay , Weber, Brittany , Hainer, Jon , Blankstein, Ron , Dey, Damini , Di Carli, Marcelo F , Huck, Daniel , Brown, Jenifer Michelle , Lopez, Diana, Lemley, Mark , Kavanagh, Paul , Liang, Joanna, Dorbala, Sharmila , Le, Viet T. , Mason, Steve, Knight, Stacey , Chareonthaitawee, Panithaya , Wopperer, Samuel, Berman, Daniel S. , Dey, Damini , Carli, Marcelo F. Di , Slomka, Piotr J

Mayo Clinic

European Heart Journal - Cardiovascular Imaging | March 26, 2026 | Volume: 27 | Issue: 6 | Pages: 1255-1265

10.1093/ehjci/jeag081 | PMID 41902398 Get It

Abstract Aims Left bundle branch block (LBBB) is associated with mechanical dyssynchrony, heterogeneous perfusion, and adverse left ventricular (LV) remodelling. However, not all patients with LBBB develop cardiomyopathy, and dyssynchrony can occur without conduction defects. The role of microvascular dysfunction remains uncertain. We aimed to assess how mechanical dyssynchrony and perfusion heterogeneity relate to LV remodelling and function in patients with and without LBBB. Methods and results We analysed 233 patients with LBBB and 932 matched controls who underwent PET myocardial perfusion imaging, assessing mechanical dyssynchrony (phase entropy), LV volumes, and ejection fraction (EF); coronary vascular resistance (CVR), myocardial blood flow (MBF), myocardial flow reserve (MFR) as markers of microvascular function; and septal-to-lateral MBF ratio (SLR) as a measure of regional perfusion heterogeneity. Compared with controls, LBBB patients had greater dyssynchrony (56% vs. 40%), larger LV volumes, and lower EF (54% vs. 67%) (all P < 0.001), as well as higher stress CVR (37 vs. 34 mmHg/mL·min−1·g−1), and lower MBF (2.4 vs. 2.6 mL/min/g), MFR (2.4 vs. 2.6), and SLR (0.95 vs. 1.00) (all P < 0.05). Among patients with dyssynchrony, SLR <1.0 identified greater remodelling. In multivariable regression, phase entropy and SLR independently predicted LV volumes and EF, with adverse effects of SLR reduction amplified in LBBB (interaction P < 0.01). In Cox analysis, phase entropy (HR:1.02, P = 0.01), MFR (HR:0.62, P < 0.001), and LVEF (HR:0.97, P < 0.001) were independently associated with death or heart failure hospitalization, whereas LBBB was not. Conclusion Mechanical dyssynchrony and perfusion heterogeneity independently predict adverse LV remodelling, irrespective of LBBB. Integrated imaging improves cardiomyopathy stratification.
Interplay of pulmonary circulation, cardiac filling pressures, and sympathovagal balance in exercise-induced hyperventilation among cardiopulmonary disorders
Vicenzi, Marco , Rodrigues, Gabriel Dias , Deboeck, Gaël , Colombo, Marinella, Rota, Irene, Mozzo, Marta , Tersalvi, Gregorio , Carugo, Stefano, Montano, Nicola, Vachiéry, Jean-Luc, Borne, Philippe van de, Vicenzi, Marco , Dias Rodrigues, Gabriel , Caravita, Sergio , Deboeck, Gael , Tersalvi, Gregorio , Tobaldini, Eleonora , Montano, Nicola , Vachiéry, Jean‐Luc , van de Borne, Philippe , Carugo, Stefano , Montano, Nicola , Borne, Philippe van de

Mayo Clinic

American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | March 23, 2026 | Volume: 330 | Issue: 5 | Pages: R480-R488

10.1152/ajpregu.00094.2025 | PMID 41870396 Get It

The results underscore a multifaceted interaction among cardiopulmonary hemodynamics, right heart pressures, ventilatory response, and autonomic regulation. In particular, altered RV-PA coupling correlated with heightened sympathetic drive, indicating that cardiopulmonary efficiency and hemodynamics may influence central autonomic outputs. This suggests that mechanical stress or overload in the right heart could modulate sympathovagal balance, thereby contributing to altered autonomic responses during exercise in patients with cardiopulmonary disorders.
Editorial. Rethinking endonasal surgery: the case for a less invasive approach
Gompel, Jamie Van, Gompel, Jamie J. Van

Mayo Clinic

Journal of Neurosurgery | March 19, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-2

10.3171/2025.9.jns252089 | PMID 41825081 Get It

Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease
Rae, Rosaria J., Alberhasky, Jessica Marie Hunter, Bangasser, Debra A. , Berteotti, Chiara, Bow, Hannah, Caldwell, Jessica Z. K., Carpi, Matteo , Ciampa, Claire J., Ehrenberg, Alexander J. , Fenlon, Haley A., Fitzhugh, Megan C. , Gallay, Clara , Hamilton, Derek A. , Hasan, Zia , Huarte, Oihane Uriarte , Jabeen, Shaista , Kolling, Louis John , Liguori, Claudio , Omoluabi, Tamunotonye, Pa, Judy, Pentkowski, Nathan S. , Pereira, Joana B., Ramos, Rhudovic R., Sargin, Derya , Seto, Mabel, Shaik, Shabana M. , Ucheagwu, Valentine , Kelberman, Michael A. , Grinberg, Lea Tenenholz, Satpati, Abhijit, Son, Gowoon, Rae, Rosaria Josephine, Baillet, Marion , Belloy, Michaël E. , Berry, Anne S. , Berteotti, Chiara , Bow, Hannah, Buckley, Rachel F. , Caldwell, Jessica K. , Clark, Benjamin J. , Conley, Alexander C. , Dahl, Martin J. , Donaldson, Zoe R. , Einstein, Gillian , Falgàs, Neus , Froemke, Robert C. , Grinberg, Lea T. , Jacobs, Heidi I.L. , Koops, Elouise A. , Lenzoni, Sabrina , Manca, Riccardo , Marcinkiewcz, Catherine Anne , Omoluabi, Tamunotonye, Oria, Rademene Sunday , Orsini, Caitlin A. , Ortega, Nancy Elizabeth , Pa, Judy , Pereira, Joana B. , Satpati, Abhijit , Sellés, María Clara , Seto, Mabel , Sindi, Shireen , Son, Gowoon , Egroo, Maxime Van , Yuan, Qi

Mayo Clinic

Alzheimer's & Dementia | March 19, 2026 | Volume: 22 | Issue: 3 | Pages: No page available

10.1002/alz.71291 | PMID 41853971 Get It

Abstract Neuromodulatory subcortical systems (NSSs) are uniquely susceptible to dementia‐related pathology, leading to frequent molecular and behavioral impairments associated with altered function of these nuclei. Some of these systems display clear sex‐specific cytoarchitecture and signaling leading to distinct physiology and behavioral outputs in males and females, while other regions display nominal sex differences. However, the relevance of sex differences in modulating dysfunction of NSSs in Alzheimer's disease (AD) and related dementias is not well understood. This review is a joint effort by the Neuromodulatory Subcortical Systems and Sex and Gender Differences in Alzheimer's Disease Professional Interest Areas of the Alzheimer's Association. We review sex differences in NSSs, both in non‐disease states and in AD models and patients. We highlight the possible role of NSSs in driving sex‐specific AD susceptibility and potential footholds for sex‐based interventions targeting these systems. We conclude by outlining immediate and long‐term actions to address the intersection of NSSs, sex, and AD.
Radiotherapy for indolent primary cutaneous B-cell lymphoma: an international multicenter ILROG analysis
Dabaja, Bouthaina S., Görlich, Dennis , Thomas, Bjorn , Sim, Van , Johnstone, P., Hashmi, Ayesha, Levis, M., Ackerson, Bradley, Hague, Christina J. , Roos, Daniel Edward, Kirova, Y., Fietkau, Rainer, Fang, Penny Q., Ng, A., Bock, Felix, Linde, Philipp , Dunst, Jürgen, Terezakis, Stephanie A, Easwaran, Teresa, Peeken, Jan C. , Wittig, Andrea, Yoon, Hong In , Illidge, Tim , Ricardi, U., Morris, S., Storck, Michael , Hoppe, Richard T, Eich, Hans Theodor, Hoppe, Richard T. , Levis, Mario , Oertel, Michael , Görlich, Dennis , Thomas, Bjorn R , Sim, Van , Levis, Mario , Weil, Christopher R , Bock, Felix , Peeken, Jan C , Yoon, Hong In , Tao, Randa , Binkley, Michael Sargent , Campbell, Belinda A , Elsayad, Khaled , Storck, Michael , Hoppe, Richard T , Hashmi, Ayesha , Weil, Christopher R. , Plastaras, John Peter , Roos, Daniel E. , Fietkau, Rainer , Fang, Penny , Tseng, Yolanda D. , Tao, Randa , Kelsey, Chris R. , Binkley, Michael S. , Eich, Hans Theodor

Mayo Clinic

Blood | March 13, 2026 | Volume: 147 | Issue: 25 | Pages: 3051-3060

10.1182/blood.2025032050 | PMID 41824381 Get It

Abstract Radiotherapy is an established treatment for low-grade primary cutaneous B-cell lymphoma. Recommendations on its use differ internationally, which prompted our group to conduct this analysis. Twenty-two institutions participated in this international study. Patient eligibility required a diagnosis of limited (T1/T2) primary cutaneous marginal zone or follicle center lymphoma treated with radiotherapy between 1995 and 2023. Data were collected retrospectively until February 2024 within the framework of the International Lymphoma Radiation Oncology Group. Overall, 535 patients were analyzed. Predominant locations were the head (40%) and trunk (36%). Radiotherapy had a median dose of 24 Gy in fractions of 2 Gy. Complete responses were observed in 91% at a median time of 3.6 months following radiotherapy. There was no statistically significant difference between treatments ≤4 Gy and >4 Gy for complete or overall response rates (P = .077 and P = .056, respectively). However, there was an inferior duration of local control with ≤4 Gy (5-year local control 73% ± 12% vs 96% ± 2%; P< .001). Radiation dose was the main prognostic factor in the univariate and multivariable Cox analysis; however, higher doses did not translate into an overall survival benefit. Toxicities rarely exceeded grade 2 but were more frequent in the >4 Gy group. Radiotherapy remains an effective treatment option for indolent skin lymphoma with low toxicity. High response rates are observed with low doses of ≤4 Gy. In comparison to conventional doses, these treatments have a shorter duration of local control but a favorable toxicity profile.